Terug naar events

Overcoming Contamination Risks During Biological Production: Mycoplasma & Virus Testing

Overcoming Contamination Risks During Biological Production: Mycoplasma & Virus Testing
12 March 2024
Start time
End time
Live webinar

Event by SGS


Any contamination introduced during the production of biologicals can pose significant potential safety risks for patients. Biopharmaceutical manufacturers must understand the most effective methods for quickly identifying sources of such contamination, particularly when developing cell and gene therapies. By doing so, it’s possible to reduce contamination risk, and cut down on costly product recalls.


In this invaluable discussion, Daniel Tatarsky will host a conversation on tracking contaminants in the biomanufacturing process as per European Pharmacopoeia and USP. Firstly, our experts will provide an overview of the contamination risks, then they will provide an in-depth review of the latest mycoplasma testing techniques. They will cover both rapid and culture methods as well as adventitious virus testing using molecular and virology methods.


  • Introduction
  • Contamination risks during biologicals production 
  • Mycoplasma testing using rapid and culture methods
  • Adventitious virus testing using molecular and virology methods
  • Q&A

Target Audience: The webinar is aimed at all experts involved in manufacturing for biopharmaceutical companies.

Language: English

Can’t make a live session? Register now and receive a complimentary recording after the live event. For further information, please contact: healthscience@sgs.com

Jean-Jacques Derriche
Jean-Jacques Derriche
Biotesting Project Leader, SGS

Jean-Jacques is taking charge of establishing our culture-based mycoplasma detection method at the SGS Health Science laboratory in Villeneuve-la-Garenne, France.

Sholto Russell
Sholto Russell
Team Leader Molecular Biology, SGS

Sholto has over 15 years of experience in molecular biology, research, development, validation and regulatory compliance, and works as the Scientific Leader at SGS’s laboratory in Glasgow, United Kingdom.

Richard Adair
Richard Adair
Senior Virology Manager, SGS

Richard worked as Clinical Research Manager at Procter & Gamble for four years, before joining Vitrology Limited in 2007. He has a Ph.D in virology from the University of Glasgow, and has completed two postdoctoral fellowships in virology at the Children’s National Medical Center, Washington D.C.; and the MRC Virology Unit, Glasgow.

Register Here